Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
Mushroom Dosage: What is the “Right” Amount of Shrooms? - DoubleBlind Mag
Psychedelics: again the pilgrimage - current experience, low/moderate dose | Good Medicine
Magic mushrooms, illegal in most places, may have therapeutic uses | The Economist
Magic Mushrooms Dosage Guide - Gwella | Mushrooms for Modern Life
Psychedelic spurs growth of neural connections lost in depression | YaleNews
DARK Classics in Chemical Neuroscience: Psilocybin | ACS Chemical Neuroscience
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey | SpringerLink
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study | Translational Psychiatry
Microdosing Psychedelics Is Trendy, But Does It Work? Here's What Science Says
Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential
Psilocybin (Magic Mushrooms) - Everything You Need to Know - Drug Science
Frontiers | Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Frontiers | Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes | Scientific Reports
Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports
Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study | Translational Psychiatry
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study - ScienceDirect
How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans | bioRxiv
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
Psychedelic microdosing benefits and challenges: an empirical codebook | Harm Reduction Journal | Full Text
Frontiers | Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
